JosephPatrickErinjeriMDPhD
Interventional Radiology • New York, NYMember, Memorial Sloan Kettering Cancer Center Professor of Radiology, Weill Cornell Medical College
Dr. Erinjeri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 East 74th Street
New York, NY 10021
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Vascular and Interventional Radiology, 2007 - 2008
New York Presbyterian Hospital (Cornell Campus)Fellowship, Vascular and Interventional Radiology, 2007 - 2008
Washington University/B-JH/SLCH ConsortiumResidency, Radiology-Diagnostic, 2003 - 2007
Virginia Mason Franciscan HealthInternship, Internal Medicine, 2002 - 2003- Washington University in St. Louis School of MedicineClass of 2002
Certifications & Licensure
NY State Medical License 2007 - 2026
NJ State Medical License 2017 - 2025- American Board of Radiology Diagnostic Radiology
- American Board of Radiology Vascular & Interventional Radiology
- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Publications & Presentations
PubMed
- Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.Sujana Movva, Kenneth Seier, Viswatej Avutu, Lauren B Banks, Jason Chan
Clinical Cancer Research. 2024-12-16 - 9 citationsCurrent Management of Desmoid Tumors: A Review.Bernd Kasper, Elizabeth H Baldini, Sylvie Bonvalot, Dario Callegaro, Kenneth Cardona
JAMA Oncology. 2024-08-01 - Adjusted Tumor Enhancement on Dual-Phase Cone-Beam CT: Predictor of Response and Overall Survival in Patients with Liver Malignancies Treated with Hepatic Artery Embol...Hooman Yarmohammadi, Fourat Ridouani, Ken Zhao, Vlasios S Sotirchos, Sam Y Son
Current Oncology. 2024-05-29
Authored Content
- Gene Signature Associated with Upregulation of the Wnt/Β-catenin Signaling Pathway Predicts Tumor Response to Transarterial EmbolizationMarch 2018
Press Mentions
- Nirogacestat May Improve Outcomes for People with SarcomaMarch 12th, 2023
- Nirogacestat Improves Outcomes for People with Sarcoma, Shows Phase 3 Clinical TrialMarch 10th, 2023
Schedule at A GlanceJune 8th, 2015- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
